Barclays Maintains Underweight on Illumina, Lowers Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Luke Sergott maintains an Underweight rating on Illumina (NASDAQ:ILMN) and has lowered the price target from $150 to $100.
September 29, 2023 | 10:05 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained an Underweight rating on Illumina and lowered the price target from $150 to $100.
The lowered price target by Barclays indicates a bearish outlook for Illumina. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100